 |
인쇄하기
취소
|
Jeil wins lawsuit over patent troll
Jeil Pharmaceutical scored a victory in a patent dispute of Baraclude (entecavir) against BMS Korea.
The Korean company said Monday that the Korean Intellectual Property Tribunal had ruled in favor of Jeil last week, which it expects will boost its entecavir business in the domestic market, whose size is over 100 billion won a year.
The Tribunal said that Jeil’s low-dose entecavir formula...
The Korean company said Monday that the Korean Intellectual Property Tribunal had ruled in favor of Jeil last week, which it expects will boost its entecavir business in the domestic market, whose size is over 100 billion won a year.
The Tribunal said that Jeil’s low-dose entecavir formula...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.